Empresa Arcadia Biosciences Inc Nasdaq
Acciones
US0390141051
Químicos agrícolas
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Plant-based Food and Beverage
99,7
%
| 9 | 90,0 % | 5 | 99,7 % | -40,70 % |
License
0,3
%
| 1 | 8,8 % | 0 | 0,3 % | -98,07 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
94,4
%
| 9 | 88,8 % | 5 | 94,4 % | -43,05 % |
Canada
5,5
%
| 0 | 1,9 % | 0 | 5,5 % | +50,00 % |
India
0,1
%
| 0 | 0,1 % | 0 | 0,1 % | -.--% |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Stanley Jacot
CEO | Chief Executive Officer | 54 | 02/02/22 |
Thomas Schaefer
DFI | Director of Finance/CFO | 48 | 01/07/20 |
Kevin Comcowich
CHM | Chairman | 55 | 01/11/16 |
Brett Michel
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Amy Yoder
BRD | Director/Board Member | 56 | 10/08/17 |
Gregory Waller
BRD | Director/Board Member | 74 | 13/06/17 |
Kevin Comcowich
CHM | Chairman | 55 | 01/11/16 |
Lilian S. Murray
BRD | Director/Board Member | 65 | 01/06/18 |
Albert Bolles
BRD | Director/Board Member | 66 | 16/05/18 |
Debbie Carosella
BRD | Director/Board Member | 67 | 22/02/21 |
Stanley Jacot
CEO | Chief Executive Officer | 54 | 02/02/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 362 840 | 1 327 434 ( 97,40 %) | 0 | 97,40 % |
Información de la empresa
Arcadia Biosciences, Inc.
5950 Sherry Lane Suite 215
75225, Dallas
+214 974 8921
http://www.arcadiabio.comVentas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+18,91 % | 37,68 mil M | |
-4,00 % | 7210,66 M | |
+3,64 % | 6636,15 M | |
-5,50 % | 5857,76 M | |
-3,05 % | 5693,78 M | |
-11,31 % | 5544,33 M | |
+29,81 % | 5130,48 M | |
-15,16 % | 4559,21 M | |
+7,72 % | 3868,68 M |